Sarissa Biomedical is a brand dedicated to making a positive impact on the world through their innovative biosensor technology. Biosensors, which are devices that contain a biological element and a transducer, play a crucial role in detecting neurochemicals in the blood. These bio-elements interact with the analyte being tested and convert the response into electrical signals.

Sarissa Biomedical is at the forefront of developing advanced biosensors that are low-cost, sensitive, and easy to use. These cutting-edge biosensors have the potential to revolutionize medicine by enabling the production of personalized medications and allowing for point-of-care detection of disease markers. By utilizing technologies such as graphene, nanotubes, and nanowires, Sarissa Biomedical is paving the way for the detection of neurochemicals, such as serotonin and dopamine, which are associated with neurological disorders.

Their biosensors provide rapid and accurate measurements of metabolic changes, making them invaluable diagnostic tools for various diseases, including Alzheimer's. With Sarissa Biomedical's innovative solutions, the future of healthcare is brighter, offering improved treatment outcomes and a better quality of life for patients